ARS Pharmaceuticals, Inc.
live · Yahoo FinanceLimited buying: $38.0M bought (counted up to $5.0M); 4 distinct insiders. Holding it back: largest buyer: Fitzpatrick Alexander A (Other C-suite), 83% of the dollars.
Score, not a recommendation.
Price and insider purchases
Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.
Loading price history…
How the score adds up
How each input is counted →| Input | Strength | Points |
|---|---|---|
| $38.0M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. | 100% | +57 |
| 4 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. | 60% | +9 |
| No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. | 0% | +0 |
| Stock 23% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. | 78% | +4 |
| 31 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. | 48% | -3 |
| Routine or plan purchases: 0% of the dollars | 100% | +0 |
| Largest buyer: Fitzpatrick Alexander A (Other C-suite), 83% of the dollars | 23% | -11 |
| Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast. | 56 | |
| Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering) | -14 | |
| Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. | 42 | |
Why are they buying?
No explanation has been generated for this cluster. The filings in the table below are the primary evidence.
| Date | InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. | Role | Shares | Price | Value | Flags | Filing |
|---|---|---|---|---|---|---|---|
| 2023-08-29 → 2023-09-21 | Kolchinsky Peter history of Kolchinsky Peter's purchases | Director | 6,450,000 | $4.87 avg | $31.4M | ||
| 2023-08-29 | Kolchinsky Peter | 3,750,000 | $6.20 | $23.2M | SEC filing for Kolchinsky Peter (opens in a new tab) | ||
| 2023-09-21 | Kolchinsky Peter | 2,508,691 | $2.97 | $7.5M | SEC filing for Kolchinsky Peter (opens in a new tab) | ||
| 2023-09-21 | Kolchinsky Peter | 191,309 | $3.83 | $732.7K | SEC filing for Kolchinsky Peter (opens in a new tab) | ||
| 2023-08-29 | Thompson Peter A. history of Thompson Peter A.'s purchases | Director | 500,000 | $6.20 | $3.1M | SEC filing for Thompson Peter A. (opens in a new tab) | |
| 2023-08-29 | ORBIMED ADVISORS LLC history of ORBIMED ADVISORS LLC's purchases | Director | 500,000 | $6.20 | $3.1M | SEC filing for ORBIMED ADVISORS LLC (opens in a new tab) | |
| 2023-09-28 → 2023-09-29 | Fitzpatrick Alexander A history of Fitzpatrick Alexander A's purchases | Other C-suite | 86,258 | $3.71 avg | $319.7K | ||
| 2023-09-28 | Fitzpatrick Alexander A | 40,000 | $3.62 | $144.8K | SEC filing for Fitzpatrick Alexander A (opens in a new tab) | ||
| 2023-09-29 | Fitzpatrick Alexander A | 46,258 | $3.78 | $174.9K | SEC filing for Fitzpatrick Alexander A (opens in a new tab) | ||
| Total | $38.0M | ||||||
Other buying runs at SPRY
A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.
After this buying run became a cluster, vs benchmark: 21 days -38.9% (-48.4% raw)63 days -32.6% (-34.9% raw)126 days +8.8% (+16.8% raw)
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2020-12-08 | 8 | $58.5M | 50 | +28.9% (+31.5% raw) | +68.0% (+74.7% raw) | -10.7% (+4.6% raw) | closed |